Viracta Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cardiff, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

SEC filing history

Showing 1-25 of 46 matching filings.

Per page
25
Current page
1
10-Q File 000-51531

10-Q Q3 2020

Filing date
16 Nov 2020
Reporting date
30 Sep 2020
Next action
Verify source filing
10-Q File 000-51531

Q2 20202 10-Q

Filing date
11 Aug 2020
Reporting date
30 Jun 2020
Next action
Verify source filing
10-Q File 000-51531

Q1 2020 10-Q

Filing date
07 May 2020
Reporting date
31 Mar 2020
Next action
Verify source filing
10-Q File 000-51531

Q3 2019 10-Q

Filing date
12 Nov 2019
Reporting date
30 Sep 2019
Next action
Verify source filing
10-Q File 000-51531

Q2 2019 10-Q

Filing date
07 Aug 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
10-Q File 000-51531

Q1 2019 10-Q

Filing date
08 May 2019
Reporting date
31 Mar 2019
Next action
Verify source filing
10-Q File 000-51531

Q3 2018 10-Q

Filing date
05 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
10-Q File 000-51531

Q2'18 10-Q

Filing date
08 Aug 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
10-Q File 000-51531

Q1 2018 10-Q

Filing date
08 May 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .